Do analysts recommend BSX or PHG?

Boston Scientific currently has a consensus target price of $71.62, indicating a potential upside of 42.12%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boston Scientific 2 Sell rating(s) 5 Hold rating(s) 24 Buy rating(s) 0 Strong Buy rating(s) 2.71 Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor BSX or PHG?

In the previous week, Boston Scientific had 48 more articles in the media than Koninklijke Philips. MarketBeat recorded 50 mentions for Boston Scientific and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat Boston Scientific's score of 1.66 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 47 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Koninklijke Philips 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor EW or PHG?

In the previous week, Edwards Lifesciences had 26 more articles in the media than Koninklijke Philips. MarketBeat recorded 28 mentions for Edwards Lifesciences and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat Edwards Lifesciences' score of 1.56 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 27 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive Koninklijke Philips 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor BDX or PHG?

In the previous week, Becton, Dickinson and Company had 31 more articles in the media than Koninklijke Philips. MarketBeat recorded 33 mentions for Becton, Dickinson and Company and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat Becton, Dickinson and Company's score of 1.20 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 24 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate IDXX or PHG?

IDEXX Laboratories currently has a consensus price target of $747.00, indicating a potential upside of 34.13%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEXX Laboratories 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60 Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer IDXX or PHG?

In the previous week, IDEXX Laboratories had 8 more articles in the media than Koninklijke Philips. MarketBeat recorded 10 mentions for IDEXX Laboratories and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat IDEXX Laboratories' score of 0.98 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer PHG or DXCM?

DexCom has a consensus target price of $88.71, indicating a potential downside of 3.93%. Given DexCom's stronger consensus rating and higher possible upside, analysts plainly believe DexCom is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 DexCom 1 Sell rating(s) 3 Hold rating(s) 21 Buy rating(s) 2 Strong Buy rating(s) 2.89

Which has preferable valuation and earnings, PHG or DXCM?

Koninklijke Philips has higher revenue and earnings than DexCom. Koninklijke Philips is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Koninklijke Philips $20.17B 1.34 $1.01B $1.36 20.18 DexCom $4.66B 7.47 $836.30M $2.53 36.50

Does the media prefer PHG or DXCM?

In the previous week, DexCom had 21 more articles in the media than Koninklijke Philips. MarketBeat recorded 23 mentions for DexCom and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat DexCom's score of 1.65 indicating that Koninklijke Philips is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive DexCom 22 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Koninklijke Philips (PHG) Competitors

$27.44 +0.02 (+0.07%)

As of 08/21/2026 03:58 PM Eastern

Compare

PHG vs. BSX, EW, BDX, IDXX, and DXCM

Should you buy Koninklijke Philips stock or one of its competitors? Koninklijke Philips's main competitors and comparable companies include Boston Scientific (BSX), Edwards Lifesciences (EW), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), and DexCom (DXCM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Koninklijke Philips compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

Boston Scientific has a net margin of 17.50% compared to Koninklijke Philips' net margin of 6.30%. Boston Scientific's return on equity of 19.28% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
Koninklijke Philips	6.30%	14.38%	5.96%

Boston Scientific currently has a consensus target price of $71.62, indicating a potential upside of 42.12%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Boston Scientific had 48 more articles in the media than Koninklijke Philips. MarketBeat recorded 50 mentions for Boston Scientific and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat Boston Scientific's score of 1.66 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	47 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Koninklijke Philips	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.3% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Boston Scientific has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.64	$2.90B	$2.47	20.40
Koninklijke Philips	$20.17B	1.34	$1.01B	$1.36	20.18

Boston Scientific has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

Summary

Boston Scientific beats Koninklijke Philips on 13 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Edwards Lifesciences?

Edwards Lifesciences (NYSE:EW) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Edwards Lifesciences has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.53	$1.07B	$1.74	51.66
Koninklijke Philips	$20.17B	1.34	$1.01B	$1.36	20.18

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Edwards Lifesciences has a net margin of 15.43% compared to Koninklijke Philips' net margin of 6.30%. Edwards Lifesciences' return on equity of 15.68% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Koninklijke Philips	6.30%	14.38%	5.96%

Edwards Lifesciences currently has a consensus target price of $100.27, suggesting a potential upside of 11.55%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Edwards Lifesciences is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Edwards Lifesciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

In the previous week, Edwards Lifesciences had 26 more articles in the media than Koninklijke Philips. MarketBeat recorded 28 mentions for Edwards Lifesciences and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat Edwards Lifesciences' score of 1.56 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	27 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Koninklijke Philips	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Edwards Lifesciences beats Koninklijke Philips on 14 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.2%. Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.1%. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Koninklijke Philips is clearly the better dividend stock, given its higher yield and lower payout ratio.

Becton, Dickinson and Company presently has a consensus target price of $185.67, indicating a potential downside of 3.27%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, equities research analysts plainly believe Becton, Dickinson and Company is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Becton, Dickinson and Company has a beta of 0.19, indicating that its share price is 81% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Koninklijke Philips has a net margin of 6.30% compared to Becton, Dickinson and Company's net margin of 4.52%. Becton, Dickinson and Company's return on equity of 14.79% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	4.52%	14.79%	6.93%
Koninklijke Philips	6.30%	14.38%	5.96%

Becton, Dickinson and Company has higher revenue and earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$21.84B	2.42	$1.68B	$3.32	57.82
Koninklijke Philips	$20.17B	1.34	$1.01B	$1.36	20.18

In the previous week, Becton, Dickinson and Company had 31 more articles in the media than Koninklijke Philips. MarketBeat recorded 33 mentions for Becton, Dickinson and Company and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat Becton, Dickinson and Company's score of 1.20 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	24 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Becton, Dickinson and Company beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

IDEXX Laboratories has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.19	$1.06B	$14.22	39.17
Koninklijke Philips	$20.17B	1.34	$1.01B	$1.36	20.18

IDEXX Laboratories has a net margin of 25.03% compared to Koninklijke Philips' net margin of 6.30%. IDEXX Laboratories' return on equity of 71.96% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Koninklijke Philips	6.30%	14.38%	5.96%

In the previous week, IDEXX Laboratories had 8 more articles in the media than Koninklijke Philips. MarketBeat recorded 10 mentions for IDEXX Laboratories and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat IDEXX Laboratories' score of 0.98 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

IDEXX Laboratories currently has a consensus price target of $747.00, indicating a potential upside of 34.13%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEXX Laboratories is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

IDEXX Laboratories has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Summary

IDEXX Laboratories beats Koninklijke Philips on 14 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to DexCom?

Koninklijke Philips (NYSE:PHG) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Koninklijke Philips has higher revenue and earnings than DexCom. Koninklijke Philips is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.34	$1.01B	$1.36	20.18
DexCom	$4.66B	7.47	$836.30M	$2.53	36.50

Koninklijke Philips has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, DexCom has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

DexCom has a net margin of 20.12% compared to Koninklijke Philips' net margin of 6.30%. DexCom's return on equity of 35.94% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
DexCom	20.12%	35.94%	14.75%

In the previous week, DexCom had 21 more articles in the media than Koninklijke Philips. MarketBeat recorded 23 mentions for DexCom and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 1.85 beat DexCom's score of 1.65 indicating that Koninklijke Philips is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
DexCom	22 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

DexCom has a consensus target price of $88.71, indicating a potential downside of 3.93%. Given DexCom's stronger consensus rating and higher possible upside, analysts plainly believe DexCom is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

DexCom beats Koninklijke Philips on 14 of the 17 factors compared between the two stocks.

Get Koninklijke Philips News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHG vs. The Competition

Export

Metric	Koninklijke Philips	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$26.97B	$5.88B	$7.32B	$24.24B
Dividend Yield	3.07%	1.75%	2.54%	3.70%
P/E Ratio	20.22	26.54	272.91	30.31
Price / Sales	1.34	70.76	639.20	20.18
Price / Cash	8.87	33.71	29.03	19.80
Price / Book	2.13	6.22	11.38	4.90
Net Income	$1.01B	$149.90M	$3.47B	$1.07B
7 Day Performance	2.20%	1.12%	2.16%	0.02%
1 Month Performance	4.91%	9.16%	7.59%	3.10%
1 Year Performance	-3.09%	8.03%	25.16%	14.90%

Koninklijke Philips Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHG Koninklijke Philips	2.9124 of 5 stars	$27.44 +0.1%	N/A	-3.1%	$26.97B	$20.17B	20.22	65,340	Positive News
BSX Boston Scientific	4.9563 of 5 stars	$51.46 -0.7%	$71.62 +39.2%	-52.5%	$75.11B	$20.07B	20.83	59,000	Positive News Gap Down
EW Edwards Lifesciences	4.3224 of 5 stars	$90.84 -0.8%	$100.27 +10.4%	+10.0%	$52.74B	$6.07B	52.21	16,000	Positive News
BDX Becton, Dickinson and Company	3.5638 of 5 stars	$182.39 -0.6%	$185.67 +1.8%	-3.8%	$50.53B	$21.84B	54.94	72,000	Positive News Gap Down
IDXX IDEXX Laboratories	4.7007 of 5 stars	$546.09 -0.9%	$747.00 +36.8%	-13.7%	$43.41B	$4.30B	38.40	11,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHG) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Koninklijke Philips (PHG) Competitors

PHG vs. BSX, EW, BDX, IDXX, and DXCM

How does Koninklijke Philips compare to Boston Scientific?

Summary

How does Koninklijke Philips compare to Edwards Lifesciences?

Summary

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Summary

How does Koninklijke Philips compare to IDEXX Laboratories?

Summary

How does Koninklijke Philips compare to DexCom?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Koninklijke Philips (PHG) Competitors

PHG vs. BSX, EW, BDX, IDXX, and DXCM

How does Koninklijke Philips compare to Boston Scientific?

Is BSX or PHG more profitable?

Do analysts recommend BSX or PHG?

Does the media favor BSX or PHG?

Do institutionals & insiders believe in BSX or PHG?

Which has stronger valuation & earnings, BSX or PHG?

Which has more volatility and risk, BSX or PHG?

Summary

How does Koninklijke Philips compare to Edwards Lifesciences?

Which has preferable valuation & earnings, EW or PHG?

Do institutionals and insiders hold more shares of EW or PHG?

Is EW or PHG more profitable?

Do analysts rate EW or PHG?

Which has more volatility & risk, EW or PHG?

Does the media favor EW or PHG?

Summary

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Is BDX or PHG a better dividend stock?

Do analysts recommend BDX or PHG?

Do insiders & institutionals have more ownership in BDX or PHG?

Which has more volatility and risk, BDX or PHG?

Is BDX or PHG more profitable?

Which has better valuation and earnings, BDX or PHG?

Does the media favor BDX or PHG?

Summary

How does Koninklijke Philips compare to IDEXX Laboratories?

Do institutionals and insiders hold more shares of IDXX or PHG?

Which has better valuation & earnings, IDXX or PHG?

Is IDXX or PHG more profitable?

Does the media prefer IDXX or PHG?

Do analysts rate IDXX or PHG?

Which has more risk and volatility, IDXX or PHG?

Summary

How does Koninklijke Philips compare to DexCom?

Which has preferable valuation and earnings, PHG or DXCM?

Which has more risk & volatility, PHG or DXCM?

Is PHG or DXCM more profitable?

Does the media prefer PHG or DXCM?

Do analysts prefer PHG or DXCM?

Do institutionals and insiders have more ownership in PHG or DXCM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools